<DOC>
	<DOCNO>NCT02980705</DOCNO>
	<brief_summary>This randomize , double-Blind , placebo-controlled Phase 2a study evaluate efficacy safety SUNPG1622 .</brief_summary>
	<brief_title>Efficacy Safety Study SUNPG1622</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Spondylarthritis</mesh_term>
	<criteria>Subject provide informed write consent Subject ≥ 18 year age time Screening Subject must stable dose NSAID ≥ 2 week prior initiation investigational product Subject negative test TB within 4 week initiate IMP Subjects know diagnosis fibromyalgia complex regional pain syndrome Active uveitis symptomatic inflammatory bowel disease require therapy screen Radiographic evidence total ankylosis spine Subject plan surgical intervention Baseline Week 24 evaluation pretreatment condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>